Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

Abstract Introduction Biologics used to treat moderate-to-severe plaque psoriasis may cause injection site reactions (ISRs) characterized by erythema, edema, itch, and sometimes pain. The Federal Adverse Event Reporting System (FAERS) is a repository of spontaneous post-marketing reports of adverse...

Full description

Bibliographic Details
Main Authors: Elsie Grace, Orin Goldblum, Lisa Renda, Noah Agada, Kyoungah See, Craig Leonardi, Alan Menter
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-11-01
Series:Dermatology and Therapy
Subjects:
Adalimumab
Biologics
Etanercept
FAERS
Injection site reactions
Ixekizumab
Online Access:http://link.springer.com/article/10.1007/s13555-019-00341-2

Internet

http://link.springer.com/article/10.1007/s13555-019-00341-2

Similar Items